Abstract:Synthesised a sequence of structurally related copper(II) complexes of Schiff base ligands, 2-[(2-benzylamino-ethylimino)-methyl]-phenol [L1(H)], 2-[(2-benzylamino-ethylimino)-methyl]-4-methyl-phenol [L2(H)], 2-[(2-benzylamino-ethylimino)-methyl]-4-bromo-phenol [L3(H)]. The complexes were characterized by ATR, UV-Vis, EPR, ESI-MS, single crystal XRD, and elemental analysis. Based on the crystal structure, ligand was coordinated to the copper(II) centre in a tridentate mode through phenolate(oxygen), imine nitrogen and amine nitrogen in a NNO fashion and the azide moiety served as an auxiliary ligand. Further, we have investigated the microbial activities of copper(II) complexes against clinically relevant fungal strains including Candida albicans, Candida glabrata, and Candida tropicalis, as well as bacteria such as Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), representing Gram-negative and Gram-positive pathogenic strains. Considering the activity of complex 2 (128-512 μg/mL) to complex 3 (64-128 μg/mL), the latter demonstrated more potent effectiveness against all of the tested fungal strains. The activity of the complexes against MRSA reveals the inhibitory concentrations for 1 (1024 μg/mL), 2 (128 μg/mL), and 3 (256 μg/mL. It is worth mentioning that, at their minimum inhibitory concentrations (MICs), the complexes are not toxic to Galleria mellonella. Furthermore, the spot and broth microdilution assay results were in good agreement with the actual metabolic viability of bacterial and fungal strains, in which the complexes were active while having no effect on the metabolite resazurin. Additionally, in silico studies have been employed to elucidate both non-bonding interactions and the mode of action across protein sequences of experimentally studied microbes. The performance of complexes closely mirrored the reactivity order determined in in vitro studies. The impeding property of complexes can be due to the dysfunctioning of virulent genes, signalling proteins, and also affects the activities of transferase and transcriptase proteins. Overall, the complexes are promising candidates for antimicrobial drug development. We anticipate utilising these molecules for clinical purposes.

Synthesis, Characterization and Bioactivity of Schiff Base Copper(Ii) Complexes Derived from L-Glutamine and L-Asparagine

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Investigation of the inherent characteristics of copper(II) Schiff base complexes as antimicrobial agents

Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate

Novel Cytotoxic Copper(II) Complexes of 8‐aminoquinoline Derivatives: Crystal Structure and Different Reactivity Towards Glutathione

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

Synthesis, Characterization, and Antibacterial and Cytotoxic Study of Metal Complexes with Schiff Base Ligands

Bioactivity Modulation: Anionic Influence on Cu(II) Schiff Base Complexes

Synthesis, Characterization, Antioxidant and Antimicrobial Activities of A Bidentate Schiff Base Ligand and Its Metal Complexes

In vitro and in silico study of the biological activity of tetradentate Schiff base copper(II) complexes with ethylenediamine-bridge

Crystal Structures and Antimicrobial and Cytotoxic Activities of Zinc(Ii), Nickel(Ii) and Copper(Ii) Complexes of N-(Piperidylthiocarbonyl) Benzamide

Synthesis, characterization, and biological activity of new mixed ligand transition metal complexes of glutamine, glutaric, and glutamic acid with nitrogen based ligands

Syntheses, Crystal Structures, and Antibacterial Activities of Four Schiff Base Complexes of Copper and Zinc

Synthesis, Characterization, Crystal Structure and Antimicrobial Activity of Copper(II) Complexes with the Schiff Base Derived from 2-Hydroxy-4-Methoxybenzaldehyde

theses, Crystal Structures and Antimicrobial Activity of Copper(II) Complexes with the Ligand N,N’-Bis(4-bromosalicylidene)propane-1,2-diamine

Novel Mn(II) and Cu(II) metal complexes with sulfa drug-derived ligands as potent antimicrobial and anticancer agents: In vitro studies, ADMET profile and molecular docking

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Synthesis, Crystal Structure, Dna Binding, Antibacterial, and Cytotoxic Activities of Two Chiral Copper(Ii) Complexes

Synthesis, Crystal Structures, Photophysical Properties and Antibacterial Activities of Copper(II) Complex Derived from 4-Chloro-2-{[(2,6-dimethylphenyl)imino]methyl}phenol

Synthesis, crystal structure and antibacterial activity of zinc(II) complexes with Schiff bases derived from 5-fluorosalicylaldehyde